Zurich (awp) – The Swiss Stock Exchange was preparing to give back part of its gains from the previous day on Tuesday, despite a positive close on Wall Street the evening before. Vigorous in the first exchanges, the main New York indices slowed down during the session.
“European markets could, however, still be under pressure with the arrival of Donald Trump in power,” warns John Plassard, at Mirabaud Banque. The analyst explains that the financial community is still struggling to understand the negative impacts of the implementation of new customs duties in the United States.
On the economic front, Germany has just noted a stagnation of inflation in October, at 2.0% year-on-year. The average unemployment rate over the three months ending at the end of September across the Channel increased more markedly than expected, to 4.3%.
At 8:10 a.m., the pre-SMI extrapolated by Julius Bär dropped 0.51% to 11,842.51 points, on a broad red front.
Pharmaceutical subcontractor Lonza (+0.5%) continues to expand its bioconjugate production capacities in Visp with the addition of two new production lines. The investment for an undisclosed amount should generate the creation of 200 jobs by 2028. The Rhineland-Valais multinational was only ahead of Geberit (+0.8%).
All the other star stocks were heading to the cellar. The traditional defensive stocks Swisscom (-0.4%) Nestlé, Novartis and Roche (-0.5% each) were already significantly behind schedule. The bottom red went to the big bank UBS, neck and neck with the luxury brand manager Richemont (-0.7% each).
On the broader market, the Zug-based real estate company PSP Swiss Property (+0.2%) increased its rental income over the first nine months of 2024, benefiting from significant revaluation effects on its real estate portfolio.
Banking software developer Temenos (-6.6%) extended the scope of its medium-term roadmap by one year during a day dedicated to investors, notably moderating its surplus target. long-term exploitation.
The Friborg company holding shares in luxury hotels and clinics Aevis Victoria (not covered) reported an increase in turnover from July to the end of September. It refrains from any comments on current or future business progress.
jh/rr
